K. Fleischer-Stępniewska

Real‐world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER study

K. Simon, A. Horban, E. Janczewska, 2016, Alimentary pharmacology & therapeutics.

Ombitasvir plus paritaprevir plus ritonavir with or without ribavirin in treatment-naive and treatment-experienced patients with genotype 4 chronic hepatitis C virus infection (PEARL-I): a randomised, open-label trial

T. Asselah, P. Marcellin, K. Reddy, 2015, The Lancet.

Genetic diagnosis of seronegative (HIV−) partner of female patient with AIDS in the context of HIV transmission

E. Piasecki, B. Knysz, Olga Błachowicz, 2016 .

O58 RESULTS FROM THE PHASE 2 PEARL-I STUDY: INTERFERON-FREE REGIMENS OF ABT-450/R + ABT-267 WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 4 INFECTION

P. Marcellin, T. Hassanein, T. Pilot‐Matias, 2014 .

Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real‐world experience study

K. Simon, E. Janczewska, R. Flisiak, 2018, Journal of viral hepatitis.

ALERT-PATHOGENS OF INTENSIVE CARE UNITS

K. Fleischer-Stępniewska, M. Fleischer, Katarzyna Fleischer-Stępniewska, 2016 .

Interferon‐free therapy as the cause of white matter tracts and cerebral perfusion recovery in patients with chronic hepatitis C

M. Inglot, M. Waliszewska-Prosół, M. Ejma, 2019, Journal of viral hepatitis.

Tubo-ovarian abscess during therapy of chronic hepatitis C with pegylated interferon and ribavirin.

A. Szymczak, M. Inglot, A. Gładysz, 2011, Neuro endocrinology letters.

Evaluation of brain volume alterations in HCV-infected patients after interferon-free therapy: A pilot study

M. Inglot, M. Waliszewska-Prosół, M. Ejma, 2019, Journal of the Neurological Sciences.

Visual and brainstem auditory evoked potentials in HCV-infected patients before and after interferon-free therapy - A pilot study.

M. Inglot, M. Waliszewska-Prosół, M. Ejma, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Effect of comedication on ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin therapy in chronic hepatitis C – a real-world study

K. Simon, A. Horban, E. Janczewska, 2019, Clinical and experimental hepatology.